1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow Carcinoid Syndrome: new trials by email Literature Review of Carcinoid Syndrome trials Research Report on Carcinoid Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation Sandostatin - Neuroendocrine Tumors, Carcinoid Syndrome | Phase 4 | Terminated | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 10 | 2016-02-02 | 2019-10-25 |
Neuroendocrine Tumors (1) · Serotonin Syndrome (1)
Chemically-Induced Disorders (1) · Drug-Related Side Effects and Adverse Reactions (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1)
Octreotide (1)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)